Yili Lu

4.5k total citations · 1 hit paper
32 papers, 3.4k citations indexed

About

Yili Lu is a scholar working on Pharmacology, Psychiatry and Mental health and Genetics. According to data from OpenAlex, Yili Lu has authored 32 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 10 papers in Psychiatry and Mental health and 9 papers in Genetics. Recurrent topics in Yili Lu's work include Treatment of Major Depression (8 papers), Estrogen and related hormone effects (7 papers) and Electroconvulsive Therapy Studies (5 papers). Yili Lu is often cited by papers focused on Treatment of Major Depression (8 papers), Estrogen and related hormone effects (7 papers) and Electroconvulsive Therapy Studies (5 papers). Yili Lu collaborates with scholars based in United States, China and Australia. Yili Lu's co-authors include D. Goldstein, Michael J. Detke, Mark A. Demitrack, Smriti Iyengar, Craig Mallinckrodt, Thomas C. Lee, Madelaine M. Wohlreich, Lesley M. Arnold, Leslie J. Crofford and Gary D. Tollefson and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and Pain.

In The Last Decade

Yili Lu

31 papers receiving 3.2k citations

Hit Papers

Duloxetine vs. placebo in patients with painful diabetic ... 2005 2026 2012 2019 2005 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Duloxetine vs. placebo in patients with painful diabetic neuropathy
    2005 613 citations D. Goldstein, Yili Lu et al. Pain profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yili Lu United States 19 1.7k 1.2k 832 569 516 32 3.4k
Yili Pritchett United States 34 1.3k 0.7× 805 0.7× 1.3k 1.6× 218 0.4× 585 1.1× 57 4.4k
Hong Liu‐Seifert United States 25 1.0k 0.6× 1.5k 1.2× 1.7k 2.0× 89 0.2× 303 0.6× 53 3.6k
Christopher Lines United States 33 1.5k 0.9× 1.8k 1.4× 1.1k 1.3× 1.3k 2.3× 1.5k 2.8× 77 5.8k
H. Robert Brashear United States 30 555 0.3× 906 0.7× 1.5k 1.8× 65 0.1× 546 1.1× 86 3.8k
Amy S. Chappell United States 26 1.5k 0.9× 995 0.8× 1.0k 1.2× 45 0.1× 542 1.1× 52 2.7k
Keijo Koivisto Finland 30 138 0.1× 1.4k 1.1× 1.2k 1.5× 165 0.3× 488 0.9× 63 3.4k
Ahmad Beydoun United States 34 281 0.2× 1.8k 1.5× 946 1.1× 49 0.1× 671 1.3× 121 3.6k
L. J. Launer United States 13 113 0.1× 667 0.5× 504 0.6× 111 0.2× 220 0.4× 19 2.6k
Lena Kilander Sweden 31 220 0.1× 1.4k 1.2× 1.3k 1.5× 143 0.3× 320 0.6× 70 3.6k
Shinji Matsunaga Japan 26 429 0.2× 561 0.5× 472 0.6× 139 0.2× 179 0.3× 70 2.0k

Countries citing papers authored by Yili Lu

Since Specialization
Citations

This map shows the geographic impact of Yili Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yili Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yili Lu more than expected).

Fields of papers citing papers by Yili Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yili Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yili Lu. The network helps show where Yili Lu may publish in the future.

Co-authorship network of co-authors of Yili Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yili Lu. A scholar is included among the top collaborators of Yili Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yili Lu. Yili Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nemeroff, Charles B., Alan F. Schatzberg, D. Goldstein, et al.. (2025). Duloxetine for the Treatment of Major Depressive Disorder. Psychopharmacology Bulletin. 36(4). 106–132. 1 indexed citations
2.
Yu, Shiwen, et al.. (2024). Novel homozygous mutations in AIRE leading to APS-1 and potential mechanisms based on bioinformatics analysis. Heliyon. 10(6). e28037–e28037. 1 indexed citations
3.
Lu, Yili & Fangli Wu. (2018). A new miRNA regulator, miR-672, reduces cardiac hypertrophy by inhibiting JUN expression. Gene. 648. 21–30. 16 indexed citations
4.
Wu, Beibei, Liying Wang, Ting Dong, et al.. (2017). Identification of a novel DMD duplication identified by a combination of MLPA and targeted exome sequencing. Molecular Cytogenetics. 10(1). 8–8. 5 indexed citations
5.
Lu, Yili, Liyin Wang, Jun Li, et al.. (2016). Molecular genetic analysis and phenotypic characteristics of a consanguineous family with glycogen storage disease type Ia. Molecular Medicine Reports. 14(4). 3251–3254. 3 indexed citations
6.
7.
Goldstein, D., Yili Lu, Michael J. Detke, Thomas C. Lee, & Smriti Iyengar. (2005). Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 116(1). 109–118. 613 indexed citations breakdown →
8.
Goldstein, D., Yili Lu, Michael J. Detke, et al.. (2004). Effects of Duloxetine on Painful Physical Symptoms Associated With Depression. Psychosomatics. 45(1). 17–28. 128 indexed citations
9.
Goldstein, D., Yili Lu, Michael J. Detke, et al.. (2004). Duloxetine in the Treatment of Depression. Journal of Clinical Psychopharmacology. 24(4). 389–399. 260 indexed citations
10.
Arnold, Lesley M., Yili Lu, Leslie J. Crofford, et al.. (2004). A double‐blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis & Rheumatism. 50(9). 2974–2984. 468 indexed citations
11.
Mallinckrodt, Craig, D. Goldstein, Michael J. Detke, Yili Lu, & Pierre V. Trân. (2003). Duloxetine. The Primary Care Companion For CNS Disorders. 5(1). 19–28. 54 indexed citations
12.
Dünner, David L., D. Goldstein, Craig Mallinckrodt, Yili Lu, & Michael J. Detke. (2003). Duloxetine in treatment of anxiety symptoms associated with depression. Depression and Anxiety. 18(2). 53–61. 59 indexed citations
13.
Detke, Michael J., Yili Lu, D. Goldstein, Robert K. McNamara, & Mark A. Demitrack. (2002). Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression. Journal of Psychiatric Research. 36(6). 383–390. 247 indexed citations
14.
Johnell, Olof, Wim H. Scheele, Yili Lu, et al.. (2002). Additive Effects of Raloxifene and Alendronate on Bone Density and Biochemical Markers of Bone Remodeling in Postmenopausal Women with Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 87(3). 985–992. 169 indexed citations
15.
Goldstein, D., Craig Mallinckrodt, Yili Lu, & Mark A. Demitrack. (2002). Duloxetine in the Treatment of Major Depressive Disorder. The Journal of Clinical Psychiatry. 63(3). 225–231. 291 indexed citations
16.
Dowsett, Mitch, N.J. Bundred, Andrea DeCensi, et al.. (2001). Effect of Raloxifene on Breast Cancer Cell Ki67 and Apoptosis. Cancer Epidemiology and Prevention Biomarkers. 10(9). 961–966. 4 indexed citations
17.
Gradishar, William J., et al.. (2000). Effects of high dose raloxifene in selected patients with advanced breast carcinoma. Cancer. 88(9). 2047–2053. 76 indexed citations
18.
19.
Trân, Pierre V., Gary D. Tollefson, T.M. Sanger, et al.. (1999). Olanzapineversushaloperidol in the treatment of schizoaffective disorder. The British Journal of Psychiatry. 174(1). 15–22. 54 indexed citations
20.
Tollefson, Gary D., et al.. (1998). Depressive Signs and Symptoms in Schizophrenia. Archives of General Psychiatry. 55(3). 250–250. 200 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yili Pritchett Breakdown of academic impact, for papers by Hong Liu‐Seifert Breakdown of academic impact, for papers by Christopher Lines Breakdown of academic impact, for papers by H. Robert Brashear Breakdown of academic impact, for papers by Amy S. Chappell Breakdown of academic impact, for papers by Keijo Koivisto Breakdown of academic impact, for papers by Ahmad Beydoun Breakdown of academic impact, for papers by L. J. Launer Breakdown of academic impact, for papers by Lena Kilander Breakdown of academic impact, for papers by Shinji Matsunaga
Rankless by CCL
2026